Fracture risk and zoledronic acid therapy in men with osteoporosis: RCT (NeLM News Service, 1 November 2012)

02 Nov 2012


An international study published in the New England Journal of Medicine assesses the antifracture efficacy of zolendronic acid for osteoporosis in men.

Full article


Related Topics

Adrenal Diabetes Metabolism Obesity Cardiovascular Bone Endocrine-Disrupting Chemicals Endocrine-Related Cancer Neuroendocrinology Reproduction Steroid and Steroidogenesis Thyroid

Share this story